Background: Syzygium aromaticum Linn. (clove) is a dried flower bud from the Myrtaceae family, native to Indonesia's Maluku islands. Clove essential oil is recognized for its diverse biological activities, including antiseptic, analgesic, antibacterial, antiviral, antifungal, and anticancer properties. Its high concentration of bioactive compounds, particularly eugenol, caryophyllene, and eugenol acetate, contributes significantly to these effects, making clove a subject of increasing scientific interest. Methods: This review compiles and analyzes updated information on the ethnomedicinal uses, phytochemistry, and pharmacological activities of clove and its primary constituent, eugenol. A systematic literature review was conducted, focusing on peer-reviewed studies that detail the extraction methods, chemical composition, and bioactivity assays of clove essential oil. Results: Clove essential oil contains approximately 16-18% of essential oils, with eugenol constituting 59-88% of its composition. The oil exhibits notable antioxidant, antimicrobial, anti-inflammatory, analgesic, antipyretic, anticancer, antidiabetic, and antiviral properties. Clove has shown efficacy against various pathogens, including Pseudomonas aeruginosa, Staphylococcus aureus, and Helicobacter pylori. Furthermore, eugenol demonstrated significant cytotoxic effects against various cancer cell lines and showed promise in managing metabolic disorders and enhancing immune responses. Conclusion: Clove and eugenol possess extensive therapeutic potential, warranting further investigation to unlock their applications in modern medicine. Despite their benefits, attention to their toxicity and safety profiles is essential for ensuring appropriate usage in therapeutic contexts. This review highlights the need for continued research to validate traditional uses and explore novel applications of clove and its bioactive components.
Read full abstract